Annual Net Income
-$35.04 M
+$2.27 M+6.09%
31 December 2022
Summary:
Zynerba Pharmaceuticals annual net profit is currently -$35.04 million, with the most recent change of +$2.27 million (+6.09%) on 31 December 2022. During the last 3 years, it has risen by +$16.30 million (+31.75%).ZYNE Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$10.78 M
-$662.30 K-6.55%
30 June 2023
Summary:
Zynerba Pharmaceuticals quarterly net profit is currently -$10.78 million, with the most recent change of -$662.30 thousand (-6.55%) on 30 June 2023.ZYNE Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$37.58 M
-$923.10 K-2.52%
30 June 2023
Summary:
Zynerba Pharmaceuticals TTM net profit is currently -$37.58 million, with the most recent change of -$923.10 thousand (-2.52%) on 30 June 2023.ZYNE TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYNE Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +31.8% | -1.8% | +1.4% |
| 5 y5 years | +12.2% | -453.6% | -25.2% |
ZYNE Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +5401.9% | +4382.6% | >+9999.0% |
Zynerba Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$10.78 M(+6.5%) | -$37.58 M(+2.5%) |
| Mar 2023 | - | -$10.11 M(+26.2%) | -$36.66 M(+4.6%) |
| Dec 2022 | -$35.04 M(-6.1%) | -$8.02 M(-7.6%) | -$35.04 M(-2.2%) |
| Sept 2022 | - | -$8.68 M(-11.9%) | -$35.83 M(-5.1%) |
| June 2022 | - | -$9.85 M(+16.0%) | -$37.74 M(-0.3%) |
| Mar 2022 | - | -$8.49 M(-3.7%) | -$37.84 M(+1.4%) |
| Dec 2021 | -$37.31 M(-27.3%) | -$8.82 M(-16.7%) | -$37.31 M(-2.1%) |
| Sept 2021 | - | -$10.58 M(+6.4%) | -$38.11 M(+4.2%) |
| June 2021 | - | -$9.95 M(+25.0%) | -$36.58 M(-22.1%) |
| Mar 2021 | - | -$7.96 M(-17.2%) | -$46.96 M(-8.5%) |
| Dec 2020 | -$51.34 M(+55.8%) | -$9.62 M(+6.3%) | -$51.34 M(-2.1%) |
| Sept 2020 | - | -$9.05 M(-55.5%) | -$52.43 M(+15.7%) |
| June 2020 | - | -$20.33 M(+64.8%) | -$45.33 M(+25.5%) |
| Mar 2020 | - | -$12.34 M(+15.1%) | -$36.13 M(+9.7%) |
| Dec 2019 | -$32.94 M(-17.5%) | -$10.71 M(+450.5%) | -$32.94 M(+9.7%) |
| Sept 2019 | - | -$1.95 M(-82.5%) | -$30.02 M(-16.3%) |
| June 2019 | - | -$11.14 M(+21.7%) | -$35.88 M(-2.4%) |
| Mar 2019 | - | -$9.15 M(+17.4%) | -$36.75 M(-7.9%) |
| Dec 2018 | -$39.91 M | -$7.79 M(-0.2%) | -$39.91 M(-0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$7.81 M(-35.0%) | -$40.24 M(-1.2%) |
| June 2018 | - | -$12.01 M(-2.4%) | -$40.74 M(+9.9%) |
| Mar 2018 | - | -$12.31 M(+51.6%) | -$37.06 M(+15.8%) |
| Dec 2017 | -$32.01 M(+36.9%) | -$8.12 M(-2.3%) | -$32.01 M(+4.0%) |
| Sept 2017 | - | -$8.31 M(-0.1%) | -$30.79 M(+8.2%) |
| June 2017 | - | -$8.32 M(+14.7%) | -$28.46 M(+7.9%) |
| Mar 2017 | - | -$7.26 M(+5.3%) | -$26.37 M(+12.7%) |
| Dec 2016 | -$23.39 M(+86.3%) | -$6.90 M(+15.3%) | -$23.39 M(+6.6%) |
| Sept 2016 | - | -$5.98 M(-4.0%) | -$21.93 M(+10.0%) |
| June 2016 | - | -$6.23 M(+45.5%) | -$19.94 M(+30.0%) |
| Mar 2016 | - | -$4.28 M(-21.3%) | -$15.34 M(+22.2%) |
| Dec 2015 | -$12.55 M(+121.4%) | -$5.44 M(+36.2%) | -$12.55 M(+47.4%) |
| Sept 2015 | - | -$3.99 M(+145.6%) | -$8.52 M(+21.0%) |
| June 2015 | - | -$1.63 M(+9.0%) | -$7.04 M(+1.7%) |
| Mar 2015 | - | -$1.49 M(+6.2%) | -$6.92 M(+22.1%) |
| Dec 2014 | -$5.67 M(+790.3%) | -$1.40 M(-44.2%) | -$5.67 M(+32.9%) |
| Sept 2014 | - | -$2.52 M(+66.6%) | -$4.27 M(+143.7%) |
| June 2014 | - | -$1.51 M(+528.0%) | -$1.75 M(+628.0%) |
| Mar 2014 | - | -$240.40 K | -$240.40 K |
| Dec 2013 | -$636.80 K | - | - |
FAQ
- What is Zynerba Pharmaceuticals annual net profit?
- What is the all time high annual net income for Zynerba Pharmaceuticals?
- What is Zynerba Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Zynerba Pharmaceuticals?
- What is Zynerba Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Zynerba Pharmaceuticals?
What is Zynerba Pharmaceuticals annual net profit?
The current annual net income of ZYNE is -$35.04 M
What is the all time high annual net income for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high annual net profit is -$636.80 K
What is Zynerba Pharmaceuticals quarterly net profit?
The current quarterly net income of ZYNE is -$10.78 M
What is the all time high quarterly net income for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high quarterly net profit is -$240.40 K
What is Zynerba Pharmaceuticals TTM net profit?
The current TTM net income of ZYNE is -$37.58 M
What is the all time high TTM net income for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high TTM net profit is -$240.40 K